Medibank Broker Firm Allocations, page-228

First 228 Last

Share
Profile

Follow
dimaz11

751 Posts.

06/11/14

18:22

Post #: 14247854
Share

Originally posted by Katavi ↑

Some comments that have come to light.
1. BUPA numbers available are for 2013 and thoughts by Instos are that they may be lower for 2014 and hence MPL may not be too far behind BUPA in terms of profitability. This may reduce price expectations for MPL post listing.
2. Overseas roadshow for USA did not seem to be easy from what I can make out. They do not have a comparable in the US for MPL and were struggling to come to terms with the low medical insurance costs in Australia compared with USA. Based on this there may be demand but not sure if they will be price leaders in the bidding process. This is good for moderating the IPO price I hope.
3. The debate whether MPL is an insurer or medical company still goes on. Believe this is why the high end of $2 is slap in the middle of insurers and medical stocks.
4. There is a lot of Insto demand. Only pricing is the issue now.
5. Some comments that broker firms were reduced in favour of public applications because in broker firm the government had to pay a 1% fee to brokers. For public pool there is no fee. Evidently government is very tight with expenses on this float. If correct, then do not expect a low IPO price ?
6. Hearing that some brokers did not allocate any stock to accounts with less than around $5000 in bro pa.
7. Hearing that 20% claw back of broker firms is probably a certainty and just lucky if it does not happen.

Expand

From what I gathered, the number of claims for Bupa does increase in 2014 which does affect their profitability. At the same time, the number of claims for Medibank has decreased. So I think there is a good prospect for Medibank to be able to reach Bupa 2013 margin level.

I havent heard any news about their USA roadshow. But their asia roadshow seems to be a success.
1 Upvote

Reply

Top Stories

Quit before you're fired: Russia bans uranium exports to USA, duplicating extant US ban

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

US election outcomes: Key economic and market takeaways

PNN

Power gets set for 1000-metre maiden drilling program in Brazil

First 228 Last

Medibank Broker Firm Allocations, page-228

Quit before you're fired: Russia bans uranium exports to USA, duplicating extant US ban

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

US election outcomes: Key economic and market takeaways

Power gets set for 1000-metre maiden drilling program in Brazil

Featured News

Featured News

Medibank Broker Firm Allocations, page-228

Top Stories

Quit before you're fired: Russia bans uranium exports to USA, duplicating extant US ban

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

US election outcomes: Key economic and market takeaways

Power gets set for 1000-metre maiden drilling program in Brazil

Featured News

Featured News